glp-1 receptors in the brain Understanding receptor agonists and their impact on drug discovery Nature: Dual-active molecules targeting GLP-1R

Cancer Inf

Continuation of Therapy If a patient is already taking a GLP-1 medication but changes insurance plans , the prior authorization can often be submitted as: Continuation of therapy Helpful documentation may include: current medication and dose duration of therapy prior weight or A1C response In some cases, continuation of therapy documentation may help bypass step therapy requirements

Funding This work was funded by the National Institute on Aging (AG057557, AG061388, AG062272, AG07664), and the National Institute on Alcohol Abuse and Alcoholism (AA029831)

[DOI] [PMC free article] [PubMed] [Google Scholar] 93.Gengler S, McClean PL, McCurtin R, Gault VA, Hlscher C

Many thanks to those who have contributedthey have greatly helped fund our summer internship programs for the past two years

Strategies on how to manage these and other side effects are described in more detail here: Figure 3 of this article and Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists